FILING OF CURRENT REPORT AND REGISTRATION STATEMENT. The Company agrees that it shall file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the SEC within the time required by the Exchange Act, relating to the transactions contemplated by, and describing the material terms and conditions of, the Transaction Documents (the “Current Report”).
Appears in 2 contracts
Sources: Equity Purchase Agreement (Yoshiharu Global Co.), Equity Purchase Agreement (Yoshiharu Global Co.)
FILING OF CURRENT REPORT AND REGISTRATION STATEMENT. The Company agrees that it shall file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the SEC within the time required by the Exchange Act, relating to the transactions contemplated by, and describing the material terms and conditions of, the Transaction Documents (the “Current Report”). The Company shall also file with the SEC, on or before May 30, 2021, a registration statement (the “Registration Statement”) covering the resale of the Put Shares.
Appears in 2 contracts
Sources: Equity Purchase Agreement (Axim Biotechnologies, Inc.), Equity Purchase Agreement (Axim Biotechnologies, Inc.)
FILING OF CURRENT REPORT AND REGISTRATION STATEMENT. The Company agrees that it shall file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the SEC within the time required by the Exchange Act, relating to the transactions contemplated by, and describing the material terms and conditions of, the Transaction Documents (the “Current Report”). The Company shall also file with the SEC, as soon as reasonably practicable after the Execution Date, a registration statement (the “Registration Statement”) covering the resale of the Put Shares.
Appears in 1 contract
Sources: Equity Purchase Agreement (Axim Biotechnologies, Inc.)
FILING OF CURRENT REPORT AND REGISTRATION STATEMENT. The Company agrees that it shall file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the SEC within the time required by the Exchange Act, relating to the transactions contemplated by, and describing the material terms and conditions of, the Transaction Documents (the “Current Report”). The Company shall also file with the SEC, on or before July 18, 2022, a registration statement (the “Registration Statement”) covering the resale of the Put Shares.
Appears in 1 contract
Sources: Equity Purchase Agreement (Axim Biotechnologies, Inc.)
FILING OF CURRENT REPORT AND REGISTRATION STATEMENT. The Company agrees that it shall file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the SEC within the time required by the Exchange Act, relating to the transactions contemplated by, and describing the material terms and conditions of, the Transaction Documents (the “Current Report”). The Company shall also file with the SEC, on or before September 30, 2020, a registration statement (the “Registration Statement”) covering the resale of the Put Shares.
Appears in 1 contract